GrowthTurtle
Data Science PhD & IEEE Fellow, Ex-Two Sigma
Synopsys looks expensive at $415.99, trading at 52 times cash earnings and 42 times next year's, against the roughly 30 times software companies usually get. That puts fair value at about $250.75 to $319.14, so buyers are paying about 30% over fair. The read is valuation levels only, based on reported earnings and revenue estimates, without fundamental work. x.comÂ
Arm's valuation carries an absurd premium for the architecture layer. It trades at 91.9x EV/sales, far above its historical range, as Wall Street prices it as the mandatory royalty tollbooth for every custom AI chip. EDA leaders Cadence, at 30.1x, and Synopsys, at 21.2x, trade near the low end of their historical bands, priced like mature utilities, as the market stacks almost all the scarcity premium into Arm. x.comÂ
Microsoft and software stocks broadly still look expensive, because AI will get exponentially better over the next two years and the market may reset software valuations much lower. Software valuations have always been ludicrous, and heavy stock-based compensation behind many software revenues is widely ignored. Winners will emerge, but picking them is not worth trying. x.com x.comÂ
Synopsys looks a bit too cheap at around 20x cash EPS. x.comÂ
Synopsys merits Overweight and a $650 December 2026 target because EDA's near-permanent switching costs give a durable recurring floor, while emulation and AI-enhanced tools lift growth and margins. Synopsys, Cadence and Siemens EDA control most of the market, and switching toolchains costs engineering years. AI chip design drives emulation hours, and ML tools command a pricing premium. The target is about 40x $16.20 of earnings power exiting 2H CY26; China export controls are the key risk. … Show more
Demand for chip-design software is booming, making Synopsys the chip-design name to own after Cadence's results. Cadence reported a record $8.2 billion backlog and raised its 2026 revenue-growth outlook to 21%; Synopsys is still about 12% below its May high, and all four models signal Long on Synopsys versus Flat on Cadence. x.comÂ
Synopsys is trading at its lowest valuation relative to Cadence in its recent history. It is up just 2% year to date, versus 32% for its closest peer. x.comÂ
Synopsys's investor day directly undercut the bear case, so the tepid stock reaction is hard to explain. It smashed 2027 revenue growth estimates and raised long-term targets for both segments. Its OpenAI partnership to jointly develop a model could look like letting the fox into the henhouse, but it is a direct admission that AI cannot bypass Synopsys's IP-protected data moat, which was the core bear argument. x.comÂ
Synopsys's OpenAI deal and investor day have blown up the bear case that frontier AI will disrupt chip-design software. When OpenAI has dominant leverage over a partner, as with Cerebras, it extracts big equity concessions; it did not with Synopsys. KeyBanc called the investor day perfectly executed, citing much better than expected initial FY27 guidance, higher long-term EDA and IP targets, margin expansion and new AWS and OpenAI partnerships, and raised its target while reiterating Overweight. … Show more
